Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/56311 
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJönsson, Bengten
dc.contributor.authorLundkvist, Jonasen
dc.date.accessioned2012-03-28T13:09:55Z-
dc.date.available2012-03-28T13:09:55Z-
dc.date.issued2002-
dc.identifier.urihttp://hdl.handle.net/10419/56311-
dc.language.isosween
dc.publisher|aStockholm School of Economics, The Economic Research Institute (EFI) |cStockholmen
dc.relation.ispartofseries|aSSE/EFI Working Paper Series in Economics and Finance |x503en
dc.subject.jelI11en
dc.subject.ddc330en
dc.subject.stwPharmazeutisches Produkten
dc.subject.stwKosten-Wirksamkeits-Analyseen
dc.subject.stwSchwedenen
dc.titleKostnadseffektivitet hos nya läkemedel: En systematisk genomgång av publicerade studier för NCEs registrerade i Sverige 1987 - 2000-
dc.typeWorking Paperen
dc.identifier.ppn353675377en
dc.rightshttp://www.econstor.eu/dspace/Nutzungsbedingungenen

Files in This Item:
File
Size
996.98 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.